Abstract:Huaiyu Jia, 1 Ying Zhang, 2 Jianzhong Ye, 1 Wenya Xu, 1 Ye Xu, 1 Weiliang Zeng, 2 Wenli Liao, 1 Tao Chen, 1 Jianming Cao, 2 Qing Wu, 1 Tieli Zhou 1 1 Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China; 2 Department of Medical Laboratory Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China Correspondence: Tieli Zhou; Qing Wu Department of Clinical Laboratory, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China Tel/Fax +86-0577-8668-9885 Email ; Background: OXA-232-producing carbapenem-resistant Klebsiella pneumoniae (CRKP) has the potential to become the "third epidemic" of carbapenem-resistant Klebsiella strain after KPC-2 and NDM in China. We investigated the first outbreak of CRKP in the First Affiliated Hospital of Wenzhou Medical University. Methods: We collected 610 clinical isolates of CRKP from the First Affiliated Hospital of Wenzhou Medical University between January 2019 and September 2020 and screened them by Polymerase Chain Reaction (PCR). The multilocus sequence typing and pulsed-field gel electrophoresis were used to determine the genetic relatedness of the strains. The antimicrobial susceptibility test was performed to determine the drug resistance of the clinical isolates. The molecular mechanism underlying carbapenem resistance was elucidated by performing PCR and conjugation experiments. The virulence potential of the strains was determined by the string test, detection of virulence-associated genes and capsular serotypes, and Galleria mellonella larval infection model. Results: Between September 2019 and May 2020, 26 OXA-232-producing CRKP were obtained from 12 patients in our hospital. Ten patients were hospitalized in the intensive care units (ICU) and the overall mortality of the inpatients involved in the outbreak was 50% (6/12). Epidemiological investigations reported that all the OXA-232-producing CRKP strains belonged to the sequence type ST15 and can be clonally transmitted among the inpatients in the ICU. All the strains had low virulence and were resistant to commonly used clinical antibiotics except for ceftazidime/avibactam, colistin, and tigecycline. The OXA-232-producing CRKP was sensitive to triclosan and chlorhexidine, and its eradication from our hospital can be achieved by the use of disinfectants in the ICU. Conclusion: In our study, OXA-232-producing CRKP isolates appeared to be clonally transmitted and the sequence type ST15 was responsible for the outbreak. Therefore, effective measurements for the infection control of CRKP are urgently needed to prevent its epidemic in the nearby region in the future. Keywords: Klebsiella pneumoniae , carbapenem-resistance, virulence, OXA-232, outbreak Data from the global surveillance programs report that OXA-48-like carbapenemases are the most common carbapenemases among the Enterobacterales strains in various countries (eg, the Middle East, North Africa, and European countries such as Belgium and Spain). 1–3 More than a dozen different variants of OXA-48-like carbapenemase have been reported and OXA-232 is currently the 3rd most common OXA-48-like derivative globally. 1 OXA-232 was produced in the Escherichia coli and K. pneumoniae strains isolated from three French patients traveling to India in 2013. 4 Since then, along with the co-production of New Delhi metallo-beta-lactamase-1, the OXA-232-producing Enterobacteriaceae especially K. pneumoniae had spread to many hospitals around the world due to international travels, leading to a huge challenge in the clinical diagnosis and treatment. 5–8 Since the initial isolation of OXA-232-producing CRKP in five neonatal patients in China in 2017, several nosocomial outbreaks of the OXA-232-producing CRKP at a small scale have been reported in children and elderly patients. 5,7 The main sequence type (ST) in the OXA-232-producing CRKP from China is ST15; but recent studies have reported that the OXA-232 is also present in ST437 K. pneumoniae clinical isolates, a newly discovered clone of high-risk multidrug-resistant (MDR) CC11. 5–7,9 Currently, a few studies have reported the virulence of OXA-232-producing CRKP. Although researchers from China have reported the OXA-232-producing CRKP with a plVPK-like virulent plasmid, its virulence level was not high. 5 Mukherjee, S. et al re -Abstract Truncated-

Emergence and transmission of the high-risk ST78 clone of OXA-48-producing Enterobacter hormaechei in a single hospital in Taiwan

Emergence of Klebsiella Pneumoniae Carbapenemase-Producing Escherichia Coli Sequence Type 131 in Hangzhou, China

Emergence of Escherichia Coli Sequence Type 131 Isolates Producing KPC-2 Carbapenemase in China.

Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant Blaoxa-232–Carrying Klebsiella Pneumoniae Sequence Type 15 Lineage

Transmission Dynamics of Carbapenem-Resistant Klebsiella Pneumoniae Sequence Type 11 Strains Carrying Capsular Loci KL64 and Rmpa/rmpa2 Genes

Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a chinese hospital

A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Enterobacterales Isolated From a Regional Hospital in Taiwan: Predominance of Carbapenemase KPC-2 and OXA-48

Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China

Molecular Mechanisms And Epidemiology Of Carbapenem-Resistant Enterobacter Cloacae Complex Isolated From Chinese Patients During 2004-2018

Emergence of Carbapenem-Resistant Klebsiella Pneumoniae Harbouring Bla OXA-48-like Genes in China

Occurrence of Enterobacter hormaechei carrying blaNDM-1 and blaKPC-2 in China.

Complete Genomic Characterization of Two Escherichia Coli Lineages Responsible for a Cluster of Carbapenem-Resistant Infections in a Chinese Hospital

Emergence of OXA-48-producing Hypervirulent Klebsiella Pneumoniae Strains in Taiwan

Detection of Plasmid-Mediated β-Lactamase Genes and Emergence of a Novel AmpC (CMH-1) in Enterobacter cloacae at a Medical Center in Southern Taiwan

Isolation of Hv-CRKP with co-production of three carbapenemases (blaKPC, blaOXA-181 or OXA-232, and blaNDM-1) and a virulence plasmid: a study from a Chinese tertiary hospital

Molecular Epidemiology, Risk Factors and Clinical Outcomes of Carbapenem-Nonsusceptible Enterobacter cloacae Complex Infections in a Taiwan University Hospital

Fusion Plasmid Enhanced the Endemic Extensively Drug Resistant Klebsiella Pneumoniae Clone ST147 Harbored Blaoxa-48 to Acquire the Hypervirulence and Cause Fatal Infection

Increased Clonal Dissemination of OXA-232-producing ST15 Klebsiella Pneumoniae in Zhejiang, China from 2018 to 2021

Outbreak of IncX8 Plasmid–Mediated KPC-3–Producing Enterobacterales Infection, China

Outbreak of Multidrug-Resistant OXA-232-Producing ST15 Klebsiella pneumoniae in a Teaching Hospital in Wenzhou, China

Clonal Dissemination of KPC-2-producing Klebsiella Pneumoniae ST11 and ST48 Clone among Multiple Departments in a Tertiary Teaching Hospital in Jiangsu Province, China.